Bio Path Holdings Stock Volatility
| BPTH Stock | USD 2.71 0.10 3.83% |
Bio Path Holdings secures Sharpe Ratio (or Efficiency) of -0.19, which signifies that the company had a -0.19% return per unit of risk over the last 3 months. Bio Path Holdings exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bio Path's Mean Deviation of 5.45, risk adjusted performance of (0.09), and Standard Deviation of 8.35 to double-check the risk estimate we provide. Key indicators related to Bio Path's volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Bio Path Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Bio daily returns, and it is calculated using variance and standard deviation. We also use Bio's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Bio Path volatility.
Bio |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Bio Path can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Bio Path at lower prices. For example, an investor can purchase Bio stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Bio Path's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Bio Stock
| 0.76 | SNDL | SNDL Inc Financial Report 20th of May 2024 | PairCorr |
| 0.68 | CGC | Canopy Growth Corp Downward Rally | PairCorr |
| 0.68 | IMCC | Im Cannabis Corp | PairCorr |
| 0.65 | PAHC | Phibro Animal Health Fiscal Year End 4th of September 2024 | PairCorr |
| 0.64 | QLI | Qilian International | PairCorr |
| 0.43 | UPC | Universe Pharmaceuticals | PairCorr |
| 0.41 | EW | Edwards Lifesciences Corp Sell-off Trend | PairCorr |
Bio Path Market Sensitivity And Downside Risk
Bio Path's beta coefficient measures the volatility of Bio stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Bio stock's returns against your selected market. In other words, Bio Path's beta of -1.24 provides an investor with an approximation of how much risk Bio Path stock can potentially add to one of your existing portfolios. Bio Path Holdings is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bio Path's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bio Path's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Bio Path Holdings Demand TrendCheck current 90 days Bio Path correlation with market (NYSE Composite)Bio Beta |
Bio standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 8.45 |
It is essential to understand the difference between upside risk (as represented by Bio Path's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Bio Path's daily returns or price. Since the actual investment returns on holding a position in bio stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Bio Path.
Bio Path Holdings Stock Volatility Analysis
Volatility refers to the frequency at which Bio Path stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Bio Path's price changes. Investors will then calculate the volatility of Bio Path's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Bio Path's volatility:
Historical Volatility
This type of stock volatility measures Bio Path's fluctuations based on previous trends. It's commonly used to predict Bio Path's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Bio Path's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Bio Path's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bio Path Holdings Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Bio Path Projected Return Density Against Market
Given the investment horizon of 90 days Bio Path Holdings has a beta of -1.2387 suggesting as returns on its benchmark rise, returns on holding Bio Path Holdings are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Bio Path is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bio Path or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bio Path's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Bio Path Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Predicted Return Density |
| Returns |
What Drives a Bio Path Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Bio Path Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Bio Path is -539.69. The daily returns are distributed with a variance of 71.44 and standard deviation of 8.45. The mean deviation of Bio Path Holdings is currently at 5.52. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.62
α | Alpha over NYSE Composite | -1.31 | |
β | Beta against NYSE Composite | -1.24 | |
σ | Overall volatility | 8.45 | |
Ir | Information ratio | -0.17 |
Bio Path Stock Return Volatility
Bio Path historical daily return volatility represents how much of Bio Path stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 8.4522% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6261% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Bio Path Volatility
Volatility is a rate at which the price of Bio Path or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Bio Path may increase or decrease. In other words, similar to Bio's beta indicator, it measures the risk of Bio Path and helps estimate the fluctuations that may happen in a short period of time. So if prices of Bio Path fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | -160.2 K | -168.2 K | |
| Market Cap | 22.8 M | 20.3 M |
Bio Path's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Bio Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Bio Path's price varies over time.
3 ways to utilize Bio Path's volatility to invest better
Higher Bio Path's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Bio Path Holdings stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Bio Path Holdings stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Bio Path Holdings investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Bio Path's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Bio Path's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Bio Path Investment Opportunity
Bio Path Holdings has a volatility of 8.45 and is 13.41 times more volatile than NYSE Composite. 74 percent of all equities and portfolios are less risky than Bio Path. You can use Bio Path Holdings to enhance the returns of your portfolios. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Bio Path to be traded at $3.25 in 90 days.Good diversification
The correlation between Bio Path Holdings and NYA is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and NYA in the same portfolio, assuming nothing else is changed.
Bio Path Additional Risk Indicators
The analysis of Bio Path's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Bio Path's investment and either accepting that risk or mitigating it. Along with some common measures of Bio Path stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 1.13 | |||
| Mean Deviation | 5.45 | |||
| Coefficient Of Variation | (606.87) | |||
| Standard Deviation | 8.35 | |||
| Variance | 69.73 | |||
| Information Ratio | (0.17) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Bio Path Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Bio Path as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Bio Path's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Bio Path's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Bio Path Holdings.
When determining whether Bio Path Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Path's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Path Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Path Holdings Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Path Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Bio Stock analysis
When running Bio Path's price analysis, check to measure Bio Path's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Path is operating at the current time. Most of Bio Path's value examination focuses on studying past and present price action to predict the probability of Bio Path's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Path's price. Additionally, you may evaluate how the addition of Bio Path to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Bio Path's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Path. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Path listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (33.63) | Return On Assets (1.03) | Return On Equity (2.20) |
The market value of Bio Path Holdings is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Path's value that differs from its market value or its book value, called intrinsic value, which is Bio Path's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Path's market value can be influenced by many factors that don't directly affect Bio Path's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Path's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Path is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Path's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.